R
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K345.7 KBRevance Therapeutics, Inc.Feb 6, 8:59 AM ET·0001193125-25-021403
- 8-K255.8 KBRevance Therapeutics, Inc.Jan 21, 8:11 AM ET·0001140361-25-001461
- 8-K202.2 KBRevance Therapeutics, Inc.Dec 12, 6:01 AM ET·0001140361-24-049072
- 8-K1.5 MBRevance Therapeutics, Inc.Dec 9, 9:17 AM ET·0001140361-24-048749
- 8-K196.4 KBRevance Therapeutics, Inc.Dec 5, 4:23 PM ET·0001140361-24-048480
- 8-K198.3 KBRevance Therapeutics, Inc.Dec 3, 8:27 AM ET·0001140361-24-048244
- 8-K198.7 KBRevance Therapeutics, Inc.Nov 29, 6:02 AM ET·0001140361-24-048023
- 8-K194.2 KBRevance Therapeutics, Inc.Nov 26, 6:01 AM ET·0001140361-24-047831
- 8-K193.9 KBRevance Therapeutics, Inc.Nov 19, 4:01 PM ET·0001140361-24-047293
- 8-K192.9 KBRevance Therapeutics, Inc.Nov 12, 6:07 AM ET·0001140361-24-045956
Insiders
10- Allouche CyrilPrincipal Financial Officer
- Beraud JillDirector
- Bertolino Arthur PeterEVP and Chief Medical Officer
- Browne L DanielDirector, CEO and President
- BYRNES ROBERT FDirector
- Coric VladDirector
- Eastman Ronald WDirector, 10% Owner
- Foley Mark JDirector, CEO
- Gangolli Julian SDirector
- GARDNER PHYLLISDirector
Tickers
No tickers on record
Addresses
business
1222 DEMONBREUN STREET SUITE 2000
NASHVILLE, TN, 37203
mailing
1222 DEMONBREUN STREET SUITE 2000
NASHVILLE, TN, 37203